News
AXGN
36.31
-2.44%
-0.91
AxoGen should be bought on weakness, says Lake Street
TipRanks · 1d ago
Down 22.6% in 4 Weeks, Here's Why You Should You Buy the Dip in AxoGen (AXGN)
NASDAQ · 1d ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 1d ago
Weekly Report: what happened at AXGN last week (0928-1002)?
Weekly Report · 1d ago
Wells Fargo Sticks to Its Buy Rating for AxoGen (AXGN)
TipRanks · 3d ago
AxoGen Acquires BioCircuit, Expands Peripheral Nerve Portfolio
TipRanks · 5d ago
Press Release: Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape(TM), the First FDA Cleared Device for Sutureless Peripheral Nerve Repair
Dow Jones · 5d ago
Axogen Price Target Cut to $53.00/Share From $60.00 by Truist Securities
Dow Jones · 5d ago
Axogen Is Maintained at Buy by Truist Securities
Dow Jones · 5d ago
Truist Securities Maintains Buy on Axogen, Lowers Price Target to $53
Benzinga · 5d ago
AxoGen price target lowered to $53 from $60 at Truist
TipRanks · 5d ago
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), AxoGen (AXGN) and Biohaven Ltd. (BHVN)
TipRanks · 6d ago
Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS) and AxoGen (AXGN)
TipRanks · 09/29 13:50
Jefferies Reaffirms Their Buy Rating on AxoGen (AXGN)
TipRanks · 09/29 12:36
Weekly Report: what happened at AXGN last week (0921-0925)?
Weekly Report · 09/28 09:18
AMD To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Friday
Benzinga · 09/25 12:56
Axogen Is Maintained at Outperform by Raymond James
Dow Jones · 09/25 12:39
Axogen Price Target Raised to $53.00/Share From $48.00 by Raymond James
Dow Jones · 09/25 12:39
Raymond James Maintains Outperform on Axogen, Raises Price Target to $53
Benzinga · 09/25 12:29
AxoGen price target raised to $53 from $48 at Raymond James
TipRanks · 09/25 11:40
More
Webull provides a variety of real-time AXGN stock news. You can receive the latest news about Axogen Inc through multiple platforms. This information may help you make smarter investment decisions.
About AXGN
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, Avive+ Soft Tissue Matrix, and NerveTape. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel.